Infectious Disease Advisor provides news updates and key opinion leader interviews from USCHA 2026, held in Anaheim, ...

Researchers evaluated changes in inpatient all-cause pneumonia rates among US adults before and after the introduction of the 13-valent pneumococcal conjugate vaccine.

Global type 1 diabetes incident cases per year are expected to increase to 605,058 by 2049, according to a study presenting at EASD.

SARS-CoV-2 infection is associated with an increased risk of 30-day mortality among adults with Staphylococcus aureus bacteremia (SAB), according to study results published in Ope ...

During the 2024-2025 season, influenza vaccines protected pediatric and adult populations against hospitalizations and ED/UC visits.

Rising hospital fees and high demand for expensive medications are expected to drive a major increase in employer healthcare costs next year.

The CDC launched a web page that gathers the nation's drug overdose numbers, prevention tips and treatment resources into a single place.

From 2005 to 2023, there was an increase in the proportion of US women who have never been screened for cervical cancer.

In traditional and expanded diagnostic criteria, obesity was independently associated with increased incidence of sepsis-associated ARDS.

The table below is a review of notable updates that occurred in August 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Mounjaro (tirzepatide) Dual glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist To reduce of the risk of major adverse cardiovascular events (MACE; ...